(Q24200953)

5

0 references

Vicki Flenady

3

0 references

Leanne Jones

2

0 references

Robert Cincotta

object named as

Robert Cincotta

4

0 references

Jodie M Dodd

object named as

Jodie M Dodd

Cochrane Database of Systematic Reviews

1

0 references

publication date

31 July 2013

0 references

published in

0 references

cites work

The use of vaginal natural progesterone for prevention of preterm birth in IVF/ICSI pregnancies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Progesterone does not prevent preterm births in women with twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Women with preterm premature rupture of the membranes do not benefit from weekly progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Progesterone and the risk of preterm birth among women with a short cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Efficacy of 17α-Hydroxyprogesterone Caproate in the Prevention of Premature Labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Does progesterone treatment influence risk factors for recurrent preterm delivery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Study of progesterone for the prevention of preterm birth in twins (STOPPIT): findings from a trial-based cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Effect of prolonged in vivo administration of progesterone in pregnancy on myometrial gene expression, peripheral blood leukocyte activation, and circulating steroid hormone levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Oral micronized progesterone for prevention of preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

A randomized controlled trial of 17-hydroxyprogesterone caproate (17-OHPC) for the prevention of preterm birth in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-α hydroxyprogesterone caproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Neonatal outcomes in twin pregnancies delivered moderately preterm, late preterm, and term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

A Comparative Study of the Efficiency of Hydroxyprogesterone Caproate and of Chlormadinone Acetate in the Prevention of Premature Labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

A randomised trial of progesterone prophylaxis after midtrimester amniocentesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

A randomized trial of cerclage vs. 17 alpha-hydroxyprogesterone caproate for treatment of short cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Prevention of premature labor by 17α-hydroxyprogesterone caproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Trial protocol OPPTIMUM-- does progesterone prophylaxis for the prevention of preterm labour improve outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Preventing preterm birth with progesterone: costs and effects of screening low risk women with a singleton pregnancy for short cervical length, the Triple P study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Rates of and factors associated with recurrence of preterm delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Hospital admissions in the first year of life in very preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

How should randomised trials including multiple pregnancies be analysed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Progesterone and preterm delivery--deja vu all over again

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Progestogen for preventing miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Supplemental progesterone to prevent preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Who remains undelivered more than seven days after a single course of prenatal corticosteroids and gives birth at less than 34 weeks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Multifactorial study of the risk of prematurity at 32 weeks of gestation. I. A study of the frequency of 30 predictive characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Interactions between progesterone receptor isoforms in myometrial cells in human labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Cervical stitch (cerclage) for preventing preterm birth in multiple pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

The epidemiology of preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Progestogens to prevent preterm birth in twin pregnancies: an individual participant data meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

A systematic review and quality assessment of systematic reviews of fetal fibronectin and transvaginal length for predicting preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Survival and cerebral palsy in low birthweight infants: implications for perinatal care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Antenatal administration of progesterone for preventing spontaneous preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

The involvement of progesterone in the onset of human labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

3: Prevention of preterm delivery after successful tocolysis in preterm labour by 17 alpha-hydroxyprogesterone caproate: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

Inhibition of oxytocin receptor function by direct binding of progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

Prolonged gynecologic and endocrine manifestations subsequent to administration of medroxyprogesterone acetate during pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

The tendency to repeat gestational age and birth weight in successive births

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

The effect of 17α-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

Preterm delivery is not predicted by serial plasma estradiol or progesterone concentration measurements

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

Racial disparity in the frequency of recurrence of preterm birth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

Cervical length changes during preterm cervical ripening: effects of 17-α-hydroxyprogesterone caproate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

Effect of medroxyprogesterone acetate upon the duration and characteristics of human gestation and labor

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

Inhibition and augmentation of progesterone production during pregnancy: effects on parturition in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

Preterm delivery: a public health perspective

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

A randomized trial of micronized progesterone for the prevention of recurrent preterm birth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

Prevention of premature birth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

A Trial of 17 Alpha-Hydroxyprogesterone Caproate to Prevent Prematurity in Twins

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

Prediction of Low Birthweight and Prematurity by a Multiple Regression Analysis with Maternal Characteristics Known since the Beginning of the Pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

Predictive value of uterine contractility and the serum levels of progesterone and oestrogens with regard to preterm labour

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

A review of the obstetric and medical complications leading to the delivery of infants of very low birthweight

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004947.PUB3

7 January 2021

10.1002/14651858.CD004947.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23903965

1 reference

Consolidated OpenCitations Corpus – April 2017